-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ankylosing spondylitis (AS) is a well-known chronic inflammatory rheumatism that causes progressive damage to the spinal structure and restricted movement.
From June 2011 to March 2018, researchers conducted a retrospective analysis of 48 consecutive AL cases, including 13 conservative treatments and 35 surgical treatments.
As a result, the average overall follow-up time was (44.
In summary, the results of the study show that surgery is still the best treatment for AL patients with ankylosing spondylitis, and the medium and long-term follow-up data prove its better clinical efficacy.
Original source:
Minhao Wu, et al.